Valuation: Bionik Laboratories Corp.

Market Cap 12 10.5 9.68 8.96 17 1.15K 17.28 115.93 45.45 562.48 45.05 44.07 1.95K P/E 2022
-0.21x
P/E 2023 -0.56x
Enterprise Value 1.98M 1.74M 1.6M 1.48M 2.81M 189M 2.86M 19.18M 7.52M 93.04M 7.45M 7.29M 322M EV / Sales 2022
0.17x
EV / Sales 2023 2.65x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.5
5 years 0
Extreme 0
2.9
10 years 0
Extreme 0
222.02
Manager TitleAgeSince
Chief Executive Officer 46 14/07/2021
Director TitleAgeSince
Director/Board Member 35 18/03/2019
Director/Board Member 70 01/09/2017
Director/Board Member 46 13/10/2022
Date Insider Type Main position Quantity % Market Cap.
13/06/23Conversion

Chairman

186,112 1.4416%
13/06/23Conversion

Director

3,102,878 24.0337%
09/06/23Buy

Director

180,555 1.3985%
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-99.98% 1.26K
+2.86%+0.24%+24.97%+2.14% 195B
-0.86%-3.39%-22.07%+24.23% 146B
+0.40%-0.33%-56.30%-13.96% 66.87B
-2.47%-3.22%+18.32%+1.19% 52.59B
+0.95%-0.77%-27.48%-30.20% 43.85B
+3.50%+2.22%+10.13%+14.18% 37.73B
+2.44%-0.57%+8.00%+42.77% 37.03B
+1.27%-0.56%-18.57%-3.41% 30.07B
+0.03%-1.32%-14.32%-18.74% 29.43B
Average +990.54%-1.70%-7.73%-8.18% 63.83B
Weighted average by Cap. +0.01%-1.81%-4.16%+5.04%

Financials

2022 2023
Net sales 1.27M 1.11M 1.03M 951K 1.8M 122M 1.83M 12.31M 4.82M 59.7M 4.78M 4.68M 207M 1.81M 1.58M 1.46M 1.35M 2.56M 172M 2.6M 17.44M 6.84M 84.62M 6.78M 6.63M 293M
Net income -10.41M -9.1M -8.4M -7.77M -14.75M -993M -14.99M -101M -39.42M -488M -39.07M -38.23M -1.69B -4.95M -4.33M -3.99M -3.69M -7.01M -472M -7.12M -47.78M -18.73M -232M -18.57M -18.17M -803M
Net Debt -1.99M -1.74M -1.61M -1.49M -2.82M -190M -2.87M -19.24M -7.54M -93.34M -7.48M -7.31M -323M 1.98M 1.74M 1.6M 1.48M 2.81M 189M 2.86M 19.18M 7.52M 93.04M 7.45M 7.29M 322M
Logo Bionik Laboratories Corp.
Bionik Laboratories Corp. is a healthcare company focused on supplying solutions to those with movement impairments. Its product portfolio includes three InMotion Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. The InMotion robots offer patient-adaptive therapy, intended to restore upper-extremity motor control for a range of neurological conditions and recovery stages, including early recovery from acute stroke. InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during therapy. Its solutions include InMotion Therapy, InMotion ARM, InMotion ARM/HAND, InMotion EVAL, InMotion Connect, InMotion for Physical Therapy, and InMotion for Occupational Therapy. InMotion Robotics provides the occupational therapist with a range of useful protocols designed to reduce many types of upper extremity neurological impairments.
Employees
12
  1. Stock Market
  2. Stocks
  3. BNKL Stock